Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bardoxolone methyl capsules
DRUG
2 trials
Sponsors
Biogen
Conditions
Autosomal Dominant Polycystic Kidney
CKD Associated With Type 1 Diabetes
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Focal Segmental Glomerulosclerosis
IgA Nephropathy
Phase 2
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
Completed
NCT03366337
Biogen
Autosomal Dominant Polycystic Kidney, CKD Associated With Type 1 Diabetes, Focal Segmental Glomerulosclerosis +1
Start: 2017-12-26
End: 2019-01-29
Updated: 2025-06-03
Phase 3
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Terminated
NCT02657356
Biogen
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Start: 2016-10-04
End: 2020-05-07
Updated: 2025-06-04